Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Explore this paper's citation graph
Summary
Groups of mice infected with 3.3 X 10(8) Staphylococcus aureus via the tail vein were treated three days later with rifampicin (13 mg/kg), vancomycin, or teicoplanin (33 mg/ kg), and rifampsicin was the most effective agent.
- Type
- article
- Published
- 1987-05-01
- Cited by
- 11
- References
- 0
- OpenAlex
- https://openalex.org/W2040640485
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:44318521
Keywords
Teicoplanin, Vancomycin, Rifampicin, Staphylococcus aureus, Medicine
References
No references recorded for this paper.
Cited by
- Pharmacodynamics of Glycopeptides in the Mouse Peritonitis Model of Streptococcus pneumoniae orStaphylococcus aureus Infection
- In vivo effect of teicoplanin and vancomycin upon haemolytic and bactericidal activity of serum against Staphylococcus aureus.
- Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus
- Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils.
- Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model
- Murine Immune Response to a Chronic Staphylococcus aureus Biofilm Infection
- Non invasive real-time monitoring of bacterial infection & therapeutic effect of anti-microbials in five mouse models
- Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.
- Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
- Teicoplanin: A New Glycopeptide Antibiotic Complex
- Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus
Related papers
- Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
- Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies
- Red-man syndrome after vancomycin: potential cross-reactivity with teicoplanin
- Comparison on In-vitro Induction of Resistance in Methicillin-resistance Staphylococcus Aureus to Vancomycin,Teicoplanin and Linezolid
- Influence of Reduced Susceptibility to Glycopeptides on Activities of Vancomycin and Teicoplanin against Staphylococcus aureus in Experimental Endocarditis
- High risk of cross‐reactivity between vancomycin and sequential teicoplanin therapy
- Vascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat model